Fresenius Medical Care Sees U.S. Plans for Kidney Disease as Positive
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
We are actively monitoring the novel coronavirus (COVID-19) pandemic. Learn About the steps that we are taking to protect our patients, employees, physicians, and partners. If you are a patient with questions or concerns, please find additional information at FreseniusKidneyCare.com and AzuraVascularCare.com
Whether your patient uses automated peritoneal dialysis (APD) or continuous ambulatory peritoneal dialysis (CAPD), the stay·safe system helps keep your patient’s treatment safe, simple and organized.
1. When compared to conventional systems, which have twice as many system openings, thus increasing the potential risk of touch contamination.
2. Port, F.K., P.J. Held, K.D. Knolph, M.N. Turenne, R.A. Wolfe. “Risk of Peritonitis and Technique Failure by CAPD Connection Technique: A National Study.” Kidney International 42 (1992): 967-974.
3. When compared to conventional systems that require the user to memorize a series of clamping and unclamping steps. Experience may vary.
Caution: Federal (US) law restricts these devices to sale by or on the order of a physician.
Note: Read the Instructions for Use for safe and proper use of these devices. For a complete description of hazards, contraindications, side effects and precautions, see full package labeling.
© 2009, 2018-2019, Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, Fresenius Renal Technologies, stay·safe, Liberty, Liberty Select, and success@home are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners. P/N 100969-01 Rev D 10/2019